The Zostavax ® vaccine for prevention of shingles (herpes zoster) is excluded from Part B Medicare coverage. Medicare manual instructions [ Medicare Benefits Manual (Pub. 100-02), Chapter 15, Section 50.4.4.2 – Immunizations ] (see below) prohibit such coverage unless the beneficiary is at risk directly related to exposure to a pathogen. In the absence of an immunocompromised state, beneficiaries are not at direct risk for developing herpes zoster. In an immunocompromised state, the vaccine is contraindicated and should not be administered. Therefore, neither the vaccine nor its administration can be covered by Part B Medicare. However, the vaccine (but not the administration) is covered under the Part D Medicare benefit. The administration fee is a beneficiary responsibility.
Medicare Benefits Manual (Pub. 100-02), Chapter 15 50.4.4.2 – Immunizations (Rev. 1, 10-01-03) A3-3157.A, B3-2049.4, HO-230.4.C
Posted: 11/28/2006 CPT codes, descriptions, and other data only are copyright 2006 American Medical Association (or such other date of publication of CPT). All Rights Reserved. Applicable FARS/DFARS Apply.
|



